StockNews.com Initiates Coverage on Arcadia Biosciences (NASDAQ:RKDA)

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report report published on Saturday. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Up 3.2 %

Shares of NASDAQ:RKDA opened at $3.32 on Friday. The business has a 50 day moving average price of $4.53 and a 200 day moving average price of $4.10. Arcadia Biosciences has a twelve month low of $1.85 and a twelve month high of $10.31. The company has a market cap of $4.54 million, a price-to-earnings ratio of -0.78 and a beta of 0.86.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences as of its most recent SEC filing. Institutional investors own 17.73% of the company’s stock.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.